Ocular Therapeutix (OCUL) Prepaid Assets (2013 - 2026)
Ocular Therapeutix (OCUL) recorded quarterly Prepaid Assets of $11.2 million in Q1 2026, up 3.29% quarter-over-quarter from $10.9 million in Q4 2025, and up 17.74% on a YoY basis from $9.5 million in Q1 2025.
Ocular Therapeutix (OCUL) Prepaid Assets (2013 - 2026) Analysis & Trends
Ocular Therapeutix's Prepaid Assets history runs 14 years deep, the most recent figure standing at $11.2 million for Q1 2026.
- In Q1 2026, Prepaid Assets rose 17.74% year-over-year to $11.2 million; the TTM figure through Mar 2026 stood at $11.2 million (up 17.74% YoY), while the FY2025 annual figure was $10.9 million, down 19.34% from the prior year.
- Prepaid Assets was $11.2 million for Q1 2026 at Ocular Therapeutix, up from $10.9 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $13.5 million in Q4 2024 to a low of $3.3 million in Q3 2022.
- Historically, Prepaid Assets has averaged $7.4 million across 5 years, with a median of $7.7 million in 2024.
- The sharpest annual moves came in 2024 and 2025: Prepaid Assets soared 170.49% in 2024, then tumbled 39.53% in 2025.
- A 5-year view of Prepaid Assets shows it stood at $4.0 million in 2022, then jumped by 93.5% to $7.8 million in 2023, then jumped by 72.66% to $13.5 million in 2024, then decreased by 19.34% to $10.9 million in 2025, then gained by 3.29% to $11.2 million in 2026.
- The last three Prepaid Assets figures came in at $11.2 million (Q1 2026), $10.9 million (Q4 2025), and $8.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Ocular Therapeutix | 2.12 Bn | 2.12 Bn | 9.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.21 Mn |
| Dec 31, 2025 | 10.86 Mn |
| Sep 30, 2025 | 7.95 Mn |
| Jun 30, 2025 | 8.79 Mn |
| Mar 31, 2025 | 9.52 Mn |
| Dec 31, 2024 | 13.46 Mn |
| Sep 30, 2024 | 13.15 Mn |
| Jun 30, 2024 | 6.12 Mn |
| Mar 31, 2024 | 7.67 Mn |
| Dec 31, 2023 | 7.79 Mn |
| Sep 30, 2023 | 4.86 Mn |
| Jun 30, 2023 | 4.59 Mn |
| Mar 31, 2023 | 4.75 Mn |
| Dec 31, 2022 | 4.03 Mn |
| Sep 30, 2022 | 3.32 Mn |
| Jun 30, 2022 | 3.80 Mn |
| Mar 31, 2022 | 4.67 Mn |
| Dec 31, 2021 | 4.75 Mn |
| Sep 30, 2021 | 3.88 Mn |
| Jun 30, 2021 | 4.82 Mn |